SGA
Sector Gamma AS Portfolio holdings
AUM
$403M
1-Year Est. Return
3.23%
1 Year Est. Return
+3.23%
AUM
$403M
AUM Growth
+$97.4M
(+32%)
Holding
44
Top Buys
| 1 | +$10.1M | |
| 2 | +$8.46M | |
| 3 | +$7.9M | |
| 4 |
Medtronic
MDT
|
+$7.57M |
| 5 |
Viatris
VTRS
|
+$6.62M |
Top Sells
| 1 | +$5.62M | |
| 2 | +$3.42M | |
| 3 | +$2.96M | |
| 4 |
TG Therapeutics
TGTX
|
+$2.95M |
| 5 |
Tenet Healthcare
THC
|
+$2.2M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Pfizer
PFE
$143B
| $31.9M | 7.91% |
1,252,086
+332,086
|
|
||
|
2
Medtronic
MDT
$131B
| $28.9M | 7.17% |
303,441
+79,441
|
|
||
3
Merck
MRK
$251B
| $27.1M | 6.71% |
322,500
+120,500
|
|
||
4
Bristol-Myers Squibb
BMY
$98.2B
| $26.2M | 6.5% |
581,267
+175,267
|
|
||
5
Becton Dickinson
BDX
$54.4B
| $20.4M | 5.05% |
108,829
+10,829
|
|
||
6
Ionis Pharmaceuticals
IONS
$13.2B
| $17.7M | 4.4% |
270,963
-14,879
|
|
||
7
Incyte
INCY
$19.9B
| $17.4M | 4.31% |
205,114
+1,114
|
|
||
8
Amgen
AMGN
$182B
| $17.3M | 4.3% |
61,456
+17,456
|
|
||
9
Gilead Sciences
GILD
$154B
| $16.3M | 4.05% |
147,239
+20,239
|
|
||
10
CVS Health
CVS
$98.5B
| $11.8M | 2.92% |
156,202
-6,798
|
|
||
11
Zimmer Biomet
ZBH
$18.7B
| $11.2M | 2.77% |
113,478
+24,847
|
|
||
12
Biogen
BIIB
$26.4B
| $10.6M | 2.62% |
75,475
+24,836
|
|
||
13
BioMarin Pharmaceuticals
BMRN
$10.4B
| $9.52M | 2.36% |
175,852
+53,504
|
|
||
14
Cardinal Health
CAH
$48.7B
| $9.34M | 2.32% |
59,536
-6,464
|
|
||
15
Thermo Fisher Scientific
TMO
$218B
| $8.95M | 2.22% |
18,444
-7,056
|
|
||
16
Baxter International
BAX
$9.68B
| $8.69M | 2.15% |
381,551
+113,544
|
|
||
17
GE HealthCare
GEHC
$36.5B
| $8.37M | 2.07% |
111,390
+37,390
|
|
||
18
Bruker
BRKR
$7.19B
| $8.15M | 2.02% |
250,909
+54,939
|
|
||
19
Centene
CNC
$19.1B
| $7.61M | 1.89% |
213,210
+61,210
|
|
||
20
Labcorp
LH
$22B
| $7.45M | 1.85% |
25,970
+6,486
|
|
||
21
PTC Therapeutics
PTCT
$6.3B
| $7.25M | 1.8% |
118,112
+25,862
|
|
||
|
22
Viatris
VTRS
$12.3B
| $6.62M | 1.64% |
+668,851
|
|
||
23
Bio-Rad Laboratories Class A
BIO
$8.59B
| $6.4M | 1.59% |
22,827
+4,998
|
|
||
24
Humana
HUM
$29.1B
| $6.23M | 1.54% |
23,942
+442
|
|
||
25
Elanco Animal Health
ELAN
$11.2B
| $6.19M | 1.53% |
307,271
+15,198
|
|